DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Cimetropium bromide

Cimetropium bromide

  • Muscarinic Acetylcholine Receptor

    Muscarinic Acetylcholine Receptor

  • The Role of Antispasmodics in Managing Irritable Bowel Syndrome

    The Role of Antispasmodics in Managing Irritable Bowel Syndrome

  • Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition

    Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition

  • IBS Treatment

    IBS Treatment

  • Pharmaceutical Appendix to the Harmonized Tariff Schedule

    Pharmaceutical Appendix to the Harmonized Tariff Schedule

  • (12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al

    (12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Current Pharmacologic Treatments of Irritable Bowel Syndrome

    Current Pharmacologic Treatments of Irritable Bowel Syndrome

  • Controlled Clinical Trial

    Controlled Clinical Trial

  • Pharmacokinetics

    Pharmacokinetics

  • Methylnaltrexone Bromide

    Methylnaltrexone Bromide

  • Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)

    Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)

  • Meta-Analysis: the Treatment of Irritable Bowel Syndrome

    Meta-Analysis: the Treatment of Irritable Bowel Syndrome

  • Product Overview

    Product Overview

  • Comparison Between the Effectiveness of Oral Phloroglucin

    Comparison Between the Effectiveness of Oral Phloroglucin

  • Pharmaceuticals Appendix

    Pharmaceuticals Appendix

  • 1720 Gastrointestinal Drugs 3

    1720 Gastrointestinal Drugs 3

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

Top View
  • Product List
  • Solutions to Pharmaceutical Issues for Anti-Cancer Drugs by Accord Excel
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Atc Index 2010
  • Irritable Bowel Syndrome. Relevance of Antispasmodics
  • Customs Tariff - Schedule
  • Customs Tariff - Schedule Xxi - 1
  • (12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • Oil in the Treatment of Irritable Bowel Effect of Fibre, Antispasmodics, And
  • IBS-Monograph-2018.Pdf
  • Medications, Dry Mouth and Dental Caries Among Older People: a Longitudinal Study
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • Review Treatment of Irritable Bowel Syndrome
  • ICD-10-CM TABLE of DRUGS and CHEMICALS
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • A European Approach to Irritable Bowel Syndrome Management
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances


© 2024 Docslib.org    Feedback